Am J Transplant, Volume 20, Suppl 3 Archives - Page 136 of 223 - ATC Abstracts

2020 American Transplant Congress
Is the Survival Impacted by Multiple Cancer after Liver Transplantation? A Retrospective French National Multicentric Study between 1993-2013
M. Altieri
Chu Caen, Caen, France
*Purpose: Introduction: Despite the great progress made in recent decades, post-liver transplant de novo cancers is one of the leading causes of late complications and…
2020 American Transplant Congress
Comparing Post-Transplant Outcomes in Living and Deceased Donor Liver Transplantation for Patients with Hepatocellular Carcinoma: An Analysis of UNOS Registry
T. Kitajima¹, D. Moonka², S. Yeddula¹, M. Rizzari¹, K. Collins¹, A. Yoshida¹, M. S. Abouljoud¹, S. Nagai¹
¹Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, ²Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI
*Purpose: Because of possible short waiting time, living donor liver transplantation (LDLT) for HCC may provide survival benefit compared to deceased donor LT (DDLT). This…
2020 American Transplant Congress
Efficacy and Tolerability of Tedizolid Phosphate in the Treatment of Mycobacterium Abscessus Infection among Pediatric Hematopoietic Stem Cell Transplant Recipients
Y. Kang, V. M. Aquino, A. Y. Koh, D. Wetzel, P. K. Sue
Pediatrics, UT Southwestern Medical Center, Dallas, TX
*Purpose: Mycobacterium abscessus complex infections are associated with high rates of morbidity and mortality in immunocompromised hosts. Treatment can be challenging due to broad spectrum…
2020 American Transplant Congress
Impact of Renal Transplant on the Outcomes of Breast Cancer Surgery
A. Choubey¹, A. Parsikia², D. Samson², M. Castaldi², R. Latifi², J. Ortiz¹
¹The University of Toledo, Toledo, OH, ²Westchester Medical Center, Valhalla, NY
*Purpose: Breast Carcinoma has the highest incidence of any cancer in adult females. The impact of a prior kidney transplant (KT) on breast cancer has…
2020 American Transplant Congress
Effect of Everolimus and Reduced Calcineurin Inhibitors on Biopsy Proven BK Virus Associated Nephropathy
Z. S. Zaky, M. Spinner, B. Stephany, S. Nurko, R. Fatica, J. Augustine, E. Poggio
Cleveland Clinic, Cleveland, OH
*Purpose: BK virus-associated nephropathy (BKVAN) is a clinically important entity that contributes to allograft loss in kidney transplant recipients (KTRs). Mammalian target of rapamycin inhibitors…
2020 American Transplant Congress
Post-Transplant Blood Borne Infectious Disease Testing in Recipients of Increased Risk Donor Livers: A Single Center Experience
J. Hendele
University of Washington, Seatttle, WA
*Purpose: Increasing the recovery and utilization of donor livers has become a key goal for transplant programs in the United States over the past decade.…
2020 American Transplant Congress
Empowering Patients to Self-Care Dialysis Previous to Kidney Transplantation Does Not Warrant Adherence to Immunosuppression
F. Ortiz¹, I. Helanterä²
¹Nephrology, Helsinki University Hospital, Helsinki, Finland, ²Kidney and Liver Transplantation, Helsinki University Hospital, Helsinki, Finland
*Purpose: Nonadherence to immunosuppression increases the risk of kidney graft loss. We hypothesized that patient education to self-care dialysis has a positive impact on adherence…
2020 American Transplant Congress
Low Food Security in Inner-City Kidney Transplant Recipients is Associated with Worse Graft Function, Lower Fruit and Vegetable Intake and Increased Psychosocial Stress
E. Kasparov, K. Cruickshank, A. Saleh, S. Pak, M. Markell
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Long-term kidney graft survival may be affected by factors other than biologic, including social determinants of health. We examined the association of the use…
2020 American Transplant Congress
Heart Transplantation Outcomes in Multiorgan Transplants
P. Kingsford¹, J. P. Li¹, C. J. Lum², A. Salimbangon³, G. Liu¹, A. M. Wolfson⁴, R. R. Chand⁵, P. Banankhah¹, P. A. Genyk¹, D. Vucicevic⁶, K. Pandya¹, J. Rahman¹, M. Fong¹, L. Grazette¹, A. Kiankhooy¹, J. Nattiv¹, S. Hashmi¹, S. B. Nuno¹, J. Pizula¹, D. J. Miklin¹, A. E. Lee¹, K. Yang¹, S. Shah¹, A. S. Vaidya¹, E. C. DePasquale¹
¹LAC+USC, Los Angeles, CA, ²The Queens Medical Center, Honolulu, HI, ³UCLA Medical Center, Los Angeles, CA, ⁴University of Arizona Sarver Heart Center, Tucson, AZ, ⁵Harbor-UCLA Medical Center, Los Angeles, CA, ⁶Newark Beth-Israel, Los Angeles, CA
*Purpose: We sought to elucidate the differences in outcomes between patients undergoing Heart-Lung (HL) Heart-Lung-Kidney (HLK) and Heart-Lung-Liver (HLL) multiorgan transplantation.*Methods: Using the UNOS registry,…
2020 American Transplant Congress
Granulocyte Colony Stimulating Factor: Trigger of Rejection in Lung Transplantation?
K. Walter¹, M. Patti¹, S. Khalid², L. Kemp¹, L. J. Lobo³, R. Coakley³, S. Krishnan³, C. T. Doligalski¹
¹University of North Carolina Medical Center, Chapel Hill, NC, ²Eshelman School of Pharmacy, Chapel Hill, NC, ³Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
*Purpose: Granulocyte colony stimulating factor (GCSF) is a management strategy for post-transplant neutropenia, but may increase the risk of rejection in lung transplant recipients (LTRs).…